<--- Back to Details
First PageDocument Content
Health / Prescription Drug User Fee Act / Center for Biologics Evaluation and Research / Biosimilar / FDA Special Protocol Assessment / New Drug Application / Generic drug / Center for Drug Evaluation and Research / Biologic / Food and Drug Administration / Pharmaceutical sciences / Medicine
Health
Prescription Drug User Fee Act
Center for Biologics Evaluation and Research
Biosimilar
FDA Special Protocol Assessment
New Drug Application
Generic drug
Center for Drug Evaluation and Research
Biologic
Food and Drug Administration
Pharmaceutical sciences
Medicine

Microsoft Word - 16618dft.doc

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 335,94 KB

Share Document on Facebook

Similar Documents

Capital Reporting Company Public Meeting on PDUFA VIU.S. FOOD & DRUG ADMINISTRATION PRESCRIPTION DRUG USER FEE ACT

DocID: 1t0K4 - View Document

Prescription Drug User Fee Act (PDUFA) Reauthorization Public Meeting August 15, 2016 1 Basic PDUFA Construct

DocID: 1sUEh - View Document

Prescription Drug User Fee Act (PDUFA) Reauthorization August 15, 2016 Page 1 1 FOOD AND DRUG ADMINISTRATION (FDA)

DocID: 1sUz3 - View Document

Health / Pharmaceutical sciences / Pharmaceutical industry / Food and Drug Administration / Advertising / Direct-to-consumer advertising / Unnecessary health care / Prescription Drug User Fee Act / Criticism of the Food and Drug Administration

United States Government Accountability Office GAO Testimony Before the Subcommittee on Oversight

DocID: 1rfHg - View Document

Health / Pharmaceuticals policy / Food and Drug Administration / Medical research / Names / Healthcare quality / Patient safety / United States Adopted Name / Prescription Drug User Fee Act / Over-the-counter drug / Medical prescription / International nonproprietary name

Best Practices in Developing Proprietary Names for Drugs

DocID: 1r8R5 - View Document